A carregar...
Levosimendan, milrinone and dobutamine in acute experimental pulmonary embolism
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Foundation. Main funding source(s): Laerdal Foundation for Acute Medicine, Novo Nordisk Foundation Background/Introduction: Acute pulmonary embolism (PE) is a frequent condition in acute cardiac care and is potentially fatal. Cause of death is right...
Na minha lista:
| Publicado no: | Eur Heart J Acute Cardiovasc Care |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8263949/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.193 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|